204 related articles for article (PubMed ID: 9371342)
1. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.
Lutsar I; Friedland IR; Wubbel L; McCoig CC; Jafri HS; Ng W; Ghaffar F; McCracken GH
Antimicrob Agents Chemother; 1998 Oct; 42(10):2650-5. PubMed ID: 9756771
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis.
McCoig CC; Wubbel L; Jafri HS; Lutsar I; Bastero R; Olsen K; Shelton S; Friedland IR; McCracken GH
J Antimicrob Chemother; 1999 May; 43(5):683-8. PubMed ID: 10382890
[TBL] [Abstract][Full Text] [Related]
5. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae.
Lodise TP; Nau R; Kinzig M; Jones RN; Drusano GL; Sörgel F
Diagn Microbiol Infect Dis; 2007 Aug; 58(4):445-52. PubMed ID: 17512154
[TBL] [Abstract][Full Text] [Related]
8. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
[TBL] [Abstract][Full Text] [Related]
10. In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Chavanet P; Beloeil H; Pechinot A; Duigou F; Buisson JC; Duong M; Neuwirth C; Kazmierczak A; Portier H
Antimicrob Agents Chemother; 1995 Aug; 39(8):1736-43. PubMed ID: 7486911
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.
Täuber MG; Doroshow CA; Hackbarth CJ; Rusnak MG; Drake TA; Sande MA
J Infect Dis; 1984 Apr; 149(4):568-74. PubMed ID: 6327835
[TBL] [Abstract][Full Text] [Related]
12. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.
Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW
J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal Evolution.
Mizrahi A; Marvaud JC; Pilmis B; Nguyen Van JC; Couzigou C; Bruel C; Engrand N; Le Monnier A; Lambert T
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31712218
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.
Rodriguez-Cerrato V; McCoig CC; Michelow IC; Ghaffar F; Jafri HS; Hardy RD; Patel C; Olsen K; McCracken GH
Antimicrob Agents Chemother; 2001 Nov; 45(11):3092-7. PubMed ID: 11600361
[TBL] [Abstract][Full Text] [Related]
16. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
Gerber CM; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
McCracken GH; Sakata Y
Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
[TBL] [Abstract][Full Text] [Related]
18. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
[TBL] [Abstract][Full Text] [Related]
19. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits.
Nau R; Schmidt T; Kaye K; Froula JL; Täuber MG
Antimicrob Agents Chemother; 1995 Mar; 39(3):593-7. PubMed ID: 7793857
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
Barry B; Muffat-Joly M; Bauchet J; Faurisson F; Gehanno P; Pocidalo JJ; Carbon C
Antimicrob Agents Chemother; 1996 Sep; 40(9):1977-82. PubMed ID: 8878566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
